Publicaciones en colaboración con investigadoras/es de Universidad de La Laguna (100)

2024

  1. A Cross-Sectional Study to Assess the Knowledge of Pharmacy Students About Drug Pollution in Spain

    American Journal of Pharmaceutical Education, Vol. 88, Núm. 9

  2. Exhaled Volatile Organic Compounds for Asthma Control Classification in Children with Moderate to Severe Asthma: Results from the SysPharmPediA Study

    American journal of respiratory and critical care medicine, Vol. 210, Núm. 9, pp. 1091-1100

  3. Haplotype-Aware Detection of SERPINA1 Variants by Nanopore Sequencing

    Journal of Molecular Diagnostics, Vol. 26, Núm. 11, pp. 971-987

  4. Multicenter Long-Term Real World Data on Treatment With Lumasiran in Patients With Primary Hyperoxaluria Type 1

    Kidney International Reports, Vol. 9, Núm. 1, pp. 114-133

2023

  1. Admixture mapping of severe asthma exacerbations in Hispanic/Latino children and youth

    Thorax, Vol. 78, Núm. 3, pp. 233-241

  2. Alpha-1 antitrypsin deficiency and Pi*S and Pi*Z SERPINA1 variants are associated with asthma exacerbations

    Pulmonology

  3. Classifying asthma control using salivary and fecal bacterial microbiome in children with moderate-to-severe asthma

    Pediatric Allergy and Immunology, Vol. 34, Núm. 2

  4. Epigenome-Wide Association Studies of the Fractional Exhaled Nitric Oxide and Bronchodilator Drug Response in Moderate-to-Severe Pediatric Asthma

    Biomedicines, Vol. 11, Núm. 3

  5. Genotypic variability in patients with clinical diagnosis of Bartter syndrome type 3

    Scientific reports, Vol. 13, Núm. 1, pp. 12587

  6. Human genetics influences microbiome composition involved in asthma exacerbations despite inhaled corticosteroid treatment

    Journal of Allergy and Clinical Immunology, Vol. 152, Núm. 3, pp. 799-806.e6

  7. Medication use in uncontrolled pediatric asthma: Results from the SysPharmPediA study

    European Journal of Pharmaceutical Sciences, Vol. 181

  8. Screening uptake of colonoscopy versus fecal immunochemical testing in first-degree relatives of patients with non-syndromic colorectal cancer: A multicenter, open-label, parallel-group, randomized trial (ParCoFit study)

    PLoS Medicine, Vol. 20, Núm. 10

  9. Sumecton reinforced gelatin-based scaffolds for cell-free bone regeneration

    International Journal of Biological Macromolecules, Vol. 249

  10. The upper-airway microbiome as a biomarker of asthma exacerbations despite inhaled corticosteroid treatment

    Journal of Allergy and Clinical Immunology, Vol. 151, Núm. 3, pp. 706-715

2022

  1. Caffeine, D-glucuronolactone and Taurine Content in Energy Drinks: Exposure and Risk Assessment

    Nutrients, Vol. 14, Núm. 23

  2. Hydrogen sulphide-triggered theranostic prodrugs based on the dynamic chemistry of tetrazines

    Chemical Communications, Vol. 58, Núm. 36, pp. 5518-5521

  3. Immigrant IBD Patients in Spain Are Younger, Have More Extraintestinal Manifestations and Use More Biologics Than Native Patients

    Frontiers in Medicine, Vol. 9

  4. Multi-ancestry genome-wide association study of asthma exacerbations

    Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology, Vol. 33, Núm. 6, pp. e13802

  5. Nanoclay-reinforced HA/alginate scaffolds as cell carriers and SDF-1 delivery-platforms for bone tissue engineering

    International Journal of Pharmaceutics, Vol. 623

  6. Prevalence of gout in the adult general population in Spain: Estimating the proportion of undiagnosed cases

    Joint Bone Spine, Vol. 89, Núm. 1